Transaction · 0001104659-26-113342

Berkowitz Noah

Berkowitz Noah, CMO, reported a transaction classified as grant at IOVANCE BIOTHERAPEUTICS, INC. involving 180000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 180000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACMO
IOVAIOVANCE BIOTHERAPEUTICS, INC.
Filing timeOct 02
Trade dateSep 30, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$14.21
Pre-filing
1mo ago1w ago -28.3%1d ago +1.7%
Returns since
7d30d90d180d1y

IOVA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
IOVA since 2026-10-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001104659-26-113342
Restricted Stock Units
Transaction date
Sep 30, 2026
Filed Oct 02, 2026, 09:01 PM · 2d delay
Shares
180k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
180k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the pu…

  2. F2

    Each RSU represents a contingent right to receive one share of the Issuer's common stock.

  3. F3

    Each performance stock unit ("PSU") converts into one share of the Issuer's common stock.

  4. F4

    Up to 135,000 shares of the Issuer's common stock underlying the PSUs may be earned subject to achievement of certain regulatory milestones.

  5. F5

    Such earned PSUs shall vest on the date that the Issuer publicly discloses on a Form 8-K with the U.S. Securities and Exchange Commission its receipt of certain regulatory milestones.

Original filing · 0001104659-26-113342
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

IOVA